Latest Articles

Building artificial DNA sounds like a technology out of science fiction, but has been conducted in labs for nearly 40 years. To make the potential of synthetic DNA a reality, new methods are being developed that aim to make creating DNA as fast as sequencing it.

New technologies are making genetic information (and the power to manipulate it) more widely available that ever before. What the public do with that information, and the effects of those actions, could be a defining theme of the 21st century.

Neuroscientists have identified the ionic basis for electroreception in sharks and their relatives, skates.

An ambitious new workflow has married two cutting-edge proteomic analysis techniques to improve imaging of large protein assemblies. The combination of electron cryo-microscopy (cryo-EM) and cross-linking coupled mass spectrometry (CX-MS) allows deeper interrogation of protein structures to a level of detail that the techniques are incapable of obtaining on their own.

Professor Shiranee Sriskandan is a Clinical Professor of Infectious Diseases at Imperial College London. She leads a team focused on the mechanisms by which streptococcal infections cause serious disease. As well as her research work, Professor Sriskandan undertakes teaching within the University and is also a medic at Hammersmith Hospital.

This article highlights the types of vaccine, trends in developing future vaccines and discusses new delivery methods and strategies to help advance our understanding of the immune system.

With olive oil’s popularity on the increase in recent years, olive oil production and sales have become big business. However, it also opens the industry up to fraudsters looking to profiteer from this trend. To tackle this problem, scientists have been exploiting differences at the chemical level to expose adulterated products.

Biotherapeutics now makes up 25% of new drugs approvals. Their efficacy and safety are highly dependent on their structures, which are complex, heterogeneous and subject to modification. Advances in mass spectrometry are allowing more information on higher order structure and new imaging techniques are even providing insights into how biological drugs behave in vivo.

Here we discuss the differences between totipotent, pluripotent, and multipotent stem cells.

The High-Performance Computing community has in recent years been dominated by the quest for Exascale systems, capable of a billion billion calculations per second. However, the interest in artificial intelligence and machine learning capabilities has pushed exascale off the front of stage. In this article, David Yip, HPC and Storage Business Development Manager at OCF, asks whether the quest for exascale is truly over.